Lv1
70 积分 2023-05-12 加入
The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study
4小时前
待确认
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
1天前
已完结
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer
1天前
已完结
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)
1天前
已完结
Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC), Especially in China
2天前
已完结
Complete shutdown of microvascular perfusion upon hepatic cryothermia is critically dependent on local tissue temperature
2天前
已完结
The role of pathological response in predicting the benefit of adjuvant therapy after neoadjuvant chemoimmunotherapy in patients with esophageal cancer
8天前
已完结
High-dose Furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A prospective real-world study
2个月前
已完结
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
3个月前
已完结
皖公网安备34019202002308
